Skip to main content
Premium Trial:

Request an Annual Quote

BioSilta Collaborates with KTH Stockholm

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — The KTH Royal Institute of Technology said today it will use screening technology from Finnish start-up BioSilta Oy for KTH's Human Protein Atlas project.

YouDoBio was also named as the distributor of BioSilta products in Sweden and Denmark.

Terms for neither deal were disclosed.

BioSilta's EnBase technology will be used to accelerate secondary screening of previously poor expressing candidates for the Human Protein Atlas project. In a statement, the two firms said they have been collaborating to optimize protein screening using microwell plates and BioSilta's enzymatic release media technology.

“By combining our knowledge we have been table to develop a very reliable screening method used to determine if a protein could be successfully expressed or not,” KTH professor and Director of Protein Science Sophia Hober said in a statement. KTH is based in Stockholm, Sweden.

“We see a great potential in the EnBase technology and hope other research groups also will find this product beneficial,” Hober added.

BioSilta is based in Oulu, Finland and uses enzymes and biocatalytic activity to advance cell culture technology.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.